在伊朗注射毒品的人群中,艾滋病毒检测趋势和相关因素 (2010-2020年)
Parya Jangipour Afshar1, Mohammad Karamouzian2,3, Ali Akbar Haghdoost4
1HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Harm reduction journal
|February 18, 2026
概括
在伊朗,注射毒品者 (PWID) 中的艾滋病毒检测在2010年至2020年间显著增加. 然而,检测率仍然很低,这凸显了需要扩大服务和有针对性的干预措施,以改善艾滋病毒预防.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 预防传染病 预防传染病
背景情况:
- 艾滋病毒检测对于预防和治疗注射毒品的人 (PWID) 和他们的网络中艾滋病毒/艾滋病至关重要.
- 了解伊朗PWID的艾滋病毒检测趋势和相关因素对于有效的公共卫生战略至关重要.
研究的目的:
- 检查2010年至2020年伊朗PWID中艾滋病毒检测的趋势.
- 确定与2020年伊朗PWID中艾滋病毒检测普及相关的因素.
主要方法:
- 利用了2010年至2020年期间对PWID进行的三次全国生物行为监测调查 (BBSS) 的数据.
- 使用Cochran-Armitage测试评估趋势,并使用后勤回归模型评估与HIV测试相关的因素.
主要成果:
- 在伊朗的PWID中,艾滋病毒检测的普及率从2010年的25.1%大幅增加到2020年的39.3%.
- 2020年,不稳定的就业,第一次吸毒的晚年年龄 (≥18岁),以及足够的艾滋病毒知识与更高的艾滋病毒检测几率有关.
结论:
- 尽管有越来越多的趋势,但伊朗的PWID中艾滋病毒检测率仍然很低.
- 建议采用诸如艾滋病毒自我检测,将检测纳入减少伤害服务和知识增强等策略,以促进检测的普及.
更多相关视频
相关概念视频
Sexually Transmitted Infections
1.3K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.3K
Pulmonary Tuberculosis I
1.0K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.0K
Retrovirus Life Cycles
49.9K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.9K
Therapeutic Drug Monitoring: Affecting Factors
258
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
258
Prevalence and Incidence
2.0K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
2.0K
Factors Affecting Drug Response: Overview
3.1K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.1K


